Origins and virulence mechanisms of uropathogenic Escherichia coli.
暂无分享,去创建一个
T. J. Wiles | R. Kulesus | M. Mulvey | Travis J Wiles | Richard R Kulesus | Matthew A Mulvey | Travis J. Wiles | M. A. Mulvey
[1] Betsy Foxman,et al. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. , 2002, The American journal of medicine.
[2] Kelly J. Wright,et al. Uropathogenic Escherichia coli Flagella Aid in Efficient Urinary Tract Colonization , 2005, Infection and Immunity.
[3] Viktoria Hancock,et al. Biofilm formation by asymptomatic and virulent urinary tract infectious Escherichia coli strains. , 2007, FEMS microbiology letters.
[4] James R. Johnson,et al. Concurrent fecal colonization with extraintestinal pathogenic Escherichia coli in a homosexual man with recurrent urinary tract infection and in his male sex partner. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] J. Hacker,et al. Molecular Basis of Commensalism in the Urinary Tract: Low Virulence or Virulence Attenuation? , 2007, Infection and Immunity.
[6] A. Hall,et al. Rho GTPases in cell biology , 2002, Nature.
[7] L. Mashburn-Warren,et al. Special delivery: vesicle trafficking in prokaryotes , 2006, Molecular microbiology.
[8] L. Wieler,et al. [Avian pathogenic Escherichia coli (APEC)]. , 2003, Berliner und Munchener tierarztliche Wochenschrift.
[9] Harry L. T. Mobley,et al. Pathogenic Escherichia coli , 2004, Nature Reviews Microbiology.
[10] F. Goñi,et al. Interaction of the bacterial protein toxin α‐haemolysin with model membranes: protein binding does not always lead to lytic activity , 1995, FEBS letters.
[11] B. Uhlin,et al. Regulatory cross‐talk between adhesin operons in Escherichia coli: inhibition of type 1 fimbriae expression by the PapB protein , 2000, The EMBO journal.
[12] Richard Bauer,et al. Uropathogenic Escherichia coli are more likely than commensal E. coli to be shared between heterosexual sex partners. , 2002, American journal of epidemiology.
[13] H. Verbrugh,et al. Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization , 1979, Infection and immunity.
[14] G. Ulett,et al. Asymptomatic bacteriuria Escherichia coli strain 83972 carries mutations in the foc locus and is unable to express F1C fimbriae. , 2006, Microbiology.
[15] S. Normark,et al. Host‐specificity of uropathogenic Escherichia coli depends on differences in binding specificity to Gal alpha 1‐4Gal‐containing isoreceptors. , 1990, The EMBO journal.
[16] I. Henderson,et al. Type V Protein Secretion Pathway: the Autotransporter Story , 2004, Microbiology and Molecular Biology Reviews.
[17] P. Humphrey,et al. Detection of Intracellular Bacterial Communities in Human Urinary Tract Infection , 2007, PLoS medicine.
[18] P. Sansonetti,et al. Calcium signalling during cell interactions with bacterial pathogens , 2004, Biology of the cell.
[19] H. Mobley,et al. Coordinate Expression of Fimbriae in Uropathogenic Escherichia coli , 2005, Infection and Immunity.
[20] H. Mobley,et al. Role of P-fimbrial-mediated adherence in pyelonephritis and persistence of uropathogenic Escherichia coli (UPEC) in the mammalian kidney. , 2007, Kidney international.
[21] C. Merril,et al. Escherichia coli K1's Capsule Is a Barrier to Bacteriophage T7 , 2005, Applied and Environmental Microbiology.
[22] W. Seeger,et al. The hemolysin of escherichia coli , 1988, European Journal of Epidemiology.
[23] C. Buchrieser,et al. How to become a uropathogen: Comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains , 2006, Proceedings of the National Academy of Sciences.
[24] D. Rasschaert,et al. Extraintestinal Pathogenic Escherichia coli Strains of Avian and Human Origin: Link between Phylogenetic Relationships and Common Virulence Patterns , 2007, Journal of Clinical Microbiology.
[25] J. Pinkner,et al. Type 1 pilus‐mediated bacterial invasion of bladder epithelial cells , 2000, The EMBO journal.
[26] J. L. Sundsbak,et al. Actin‐gated intracellular growth and resurgence of uropathogenic Escherichia coli , 2006, Cellular microbiology.
[27] R. Conran,et al. Mutation of the Gene Encoding Cytotoxic Necrotizing Factor Type 1 (cnf1) Attenuates the Virulence of Uropathogenic Escherichia coli , 2001, Infection and Immunity.
[28] L. Wieler,et al. Avian pathogenic, uropathogenic, and newborn meningitis-causing Escherichia coli: how closely related are they? , 2007, International journal of medical microbiology : IJMM.
[29] L. Pavone,et al. Engagement of integrins as a cellular route of invasion by bacterial pathogens. , 2007, Veterinary journal.
[30] Göran Widmalm,et al. The structures of Escherichia coli O-polysaccharide antigens. , 2006, FEMS microbiology reviews.
[31] Harry L. T. Mobley,et al. Sat, the Secreted Autotransporter Toxin of Uropathogenic Escherichia coli, Is a Vacuolating Cytotoxin for Bladder and Kidney Epithelial Cells , 2002, Infection and Immunity.
[32] H. Akaza,et al. Type 1, P and S fimbriae, and afimbrial adhesin I are not essential for uropathogenic Escherichia coli to adhere to and invade bladder epithelial cells. , 2002, FEMS immunology and medical microbiology.
[33] G. Ulett,et al. The Asymptomatic Bacteriuria Escherichia coli Strain 83972 Outcompetes Uropathogenic E. coli Strains in Human Urine , 2006, Infection and Immunity.
[34] F. Blattner,et al. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[35] G. Waksman,et al. Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection , 2002, Molecular microbiology.
[36] B. Foxman,et al. Escherichia coli mediated urinary tract infections: are there distinct uropathogenic E. coli (UPEC) pathotypes? , 2005, FEMS microbiology letters.
[37] J. Hacker,et al. Loss of Regulatory Protein RfaH Attenuates Virulence of Uropathogenic Escherichia coli , 2002, Infection and Immunity.
[38] R. Strong,et al. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. , 2002, Molecular cell.
[39] Kelly J. Wright,et al. Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili , 2007, Cellular microbiology.
[40] F. Bäckhed,et al. Role of the Lipopolysaccharide-CD14 Complex for the Activity of Hemolysin from Uropathogenic Escherichia coli , 2006, Infection and Immunity.
[41] S. Hultgren,et al. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. , 1998, Science.
[42] C. Svanborg,et al. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[43] E. Nielsen,et al. Asymptomatic bacteriuria Escherichia coli strains: adhesins, growth and competition. , 2006, FEMS microbiology letters.
[44] U. Dobrindt,et al. Demonstration of regulatory cross-talk between P fimbriae and type 1 fimbriae in uropathogenic Escherichia coli. , 2006, Microbiology.
[45] W. Donovan,et al. Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients. , 2000, The Journal of urology.
[46] J. Saunders,et al. Contribution of capsular polysaccharide and surface properties to virulence of Escherichia coli K1 , 1987, Infection and immunity.
[47] B. Bishop,et al. TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder. , 2007, Cell host & microbe.
[48] J. R. Johnson,et al. Virulence factors in Escherichia coli urinary tract infection , 1991, Clinical Microbiology Reviews.
[49] J. R. Johnson,et al. Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. , 2000, The Journal of infectious diseases.
[50] F. Bäckhed,et al. α-Haemolysin of uropathogenic E. coli induces Ca 2+ oscillations in renal epithelial cells , 2000, Nature.
[51] C. Tang,et al. Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract , 2002, Molecular microbiology.
[52] S. Bhakdi,et al. Why Escherichia coli α‐hemolysin induces calcium oscillations in mammalian cells‐the pore is on its own , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[53] T. Johnson,et al. Characterizing the APEC pathotype. , 2005, Veterinary research.
[54] S. Wai,et al. Release of the type I secreted α‐haemolysin via outer membrane vesicles from Escherichia coli , 2006 .
[55] N. Baker,et al. Binding specificities of wild-type and cloned Escherichia coli strains that recognize globo-A , 1989, Infection and immunity.
[56] A. Stapleton,et al. Chromosomal restriction fragment length polymorphism analysis of Escherichia coli strains causing recurrent urinary tract infections in young women. , 1995, The Journal of infectious diseases.
[57] R. Darouiche,et al. Virulence Properties of Escherichia coli83972, a Prototype Strain Associated with Asymptomatic Bacteriuria , 1999, Infection and Immunity.
[58] V. Parreira,et al. A Novel Pathogenicity Island Integrated Adjacent to the thrW tRNA Gene of Avian Pathogenic Escherichia coli Encodes a Vacuolating Autotransporter Toxin , 2003, Infection and Immunity.
[59] P. Klemm,et al. Global Gene Expression Profiling of the Asymptomatic Bacteriuria Escherichia coli Strain 83972 in the Human Urinary Tract , 2006, Infection and Immunity.
[60] T. Johnson,et al. Acquisition of Avian Pathogenic Escherichia coli Plasmids by a Commensal E. coli Isolate Enhances Its Abilities To Kill Chicken Embryos, Grow in Human Urine, and Colonize the Murine Kidney , 2006, Infection and Immunity.
[61] C. Dozois,et al. Autotransporter-Encoding Sequences Are Phylogenetically Distributed among Escherichia coli Clinical Isolates and Reference Strains , 2007, Applied and Environmental Microbiology.
[62] David R. Liu,et al. The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2 , 2006, Proceedings of the National Academy of Sciences.
[63] M. Achtman,et al. Role of the capsule and the O antigen in resistance of O18:K1 Escherichia coli to complement-mediated killing , 1983, Infection and immunity.
[64] J Hacker,et al. Pathogenicity islands of virulent bacteria: structure, function and impact on microbial evolution , 1997, Molecular microbiology.
[65] D. Polk,et al. Commensal bacteria in the gut: learning who our friends are , 2004, Current opinion in gastroenterology.
[66] S. Langermann,et al. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. , 1997, Science.
[67] J. Hacker,et al. Active Cytotoxic Necrotizing Factor 1 Associated with Outer Membrane Vesicles from Uropathogenic Escherichia coli , 2006, Infection and Immunity.
[68] A. O’Brien,et al. Cytotoxic Necrotizing Factor Type 1 of Uropathogenic Escherichia coli Kills Cultured Human Uroepithelial 5637 Cells by an Apoptotic Mechanism , 2000, Infection and Immunity.
[69] L. Truong,et al. pap-2-encoded fimbriae adhere to the P blood group-related glycosphingolipid stage-specific embryonic antigen 4 in the human kidney , 1990, Infection and immunity.
[70] B. Finlay,et al. Pathogenicity islands: a molecular toolbox for bacterial virulence , 2006, Cellular microbiology.
[71] I. Snyder,et al. Effect of Escherichia coli alpha-hemolysin on human peripheral leukocyte function in vitro , 1982, Infection and Immunity.
[72] S. Hultgren,et al. Intracellular Bacterial Biofilm-Like Pods in Urinary Tract Infections , 2003, Science.
[73] K. Mori,et al. Cell biology: Iron thievery , 2004, Nature.
[74] D. Rasko,et al. Defining Genomic Islands and Uropathogen-Specific Genes in Uropathogenic Escherichia coli , 2007, Journal of bacteriology.
[75] W. Rabsch,et al. Salmochelins, siderophores of Salmonella enterica and uropathogenic Escherichia coli strains, are recognized by the outer membrane receptor IroN , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[76] M. Kuehn,et al. Bacterial outer membrane vesicles and the host-pathogen interaction. , 2005, Genes & development.
[77] J. L. Sundsbak,et al. Integrin-Mediated Host Cell Invasion by Type 1–Piliated Uropathogenic Escherichia coli , 2007, PLoS pathogens.
[78] E. Bingen,et al. Combined multilocus sequence typing and O serogrouping distinguishes Escherichia coli subtypes associated with infant urosepsis and/or meningitis. , 2007, The Journal of infectious diseases.
[79] T. J. Wiles,et al. Inactivation of host Akt/protein kinase B signaling by bacterial pore-forming toxins. , 2008, Molecular biology of the cell.
[80] S. Andrews,et al. Bacterial iron homeostasis. , 2003, FEMS microbiology reviews.
[81] Hening Lin,et al. How pathogenic bacteria evade mammalian sabotage in the battle for iron , 2006, Nature chemical biology.
[82] S. Hakomori,et al. The Globoseries Glycosphingolipid Sialosyl Galactosyl Globoside Is Found in Urinary Tract Tissues and Is a Preferred Binding Receptor In Vitro for Uropathogenic Escherichia coli Expressing pap-Encoded Adhesins , 1998, Infection and Immunity.
[83] S. Kariyawasam,et al. Common and specific genomic sequences of avian and human extraintestinal pathogenic Escherichia coli as determined by genomic subtractive hybridization. , 2007, BMC microbiology.
[84] Shizuo Akira,et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron , 2004, Nature.
[85] A. Nelson,et al. Epithelial Cells Are Sensitive Detectors of Bacterial Pore-forming Toxins* , 2006, Journal of Biological Chemistry.
[86] E. Ron. Host specificity of septicemic Escherichia coli: human and avian pathogens. , 2006, Current opinion in microbiology.
[87] P. Cossart,et al. Histone modifications induced by a family of bacterial toxins , 2007, Proceedings of the National Academy of Sciences.
[88] Kelly D. Smith. Iron metabolism at the host pathogen interface: lipocalin 2 and the pathogen-associated iroA gene cluster. , 2007, The international journal of biochemistry & cell biology.
[89] K. Hantke,et al. The structure of salmochelins: C-glucosylated enterobactins of Salmonella enterica§ , 2004, Biometals.
[90] J. R. Johnson,et al. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. , 2001, The New England journal of medicine.
[91] Curt Doetkott,et al. The Genome Sequence of Avian Pathogenic Escherichia coli Strain O1:K1:H7 Shares Strong Similarities with Human Extraintestinal Pathogenic E. coli Genomes , 2007, Journal of bacteriology.
[92] J. Hacker,et al. Pathogenicity islands and the evolution of microbes. , 2000, Annual review of microbiology.
[93] H. Mobley,et al. Role of Motility in the Colonization of Uropathogenic Escherichia coli in the Urinary Tract , 2005, Infection and Immunity.
[94] A. O’Brien,et al. Cytotoxic Necrotizing Factor Type 1 Delivered by Outer Membrane Vesicles of Uropathogenic Escherichia coli Attenuates Polymorphonuclear Leukocyte Antimicrobial Activity and Chemotaxis , 2006, Infection and Immunity.
[95] D. Eto,et al. Covert Operations of Uropathogenic Escherichia coli within the Urinary Tract , 2005, Traffic.
[96] H. Mobley,et al. Protease Activity, Secretion, Cell Entry, Cytotoxicity, and Cellular Targets of Secreted Autotransporter Toxin of Uropathogenic Escherichia coli , 2006, Infection and Immunity.
[97] Scott J. Hultgren,et al. Functional Genomic Studies of Uropathogenic Escherichia coli and Host Urothelial Cells when Intracellular Bacterial Communities Are Assembled* , 2007, Journal of Biological Chemistry.
[98] R. Welch,et al. Domains of Escherichia coli hemolysin (HlyA) involved in binding of calcium and erythrocyte membranes , 1990, Infection and immunity.
[99] R. Welch,et al. Calcium is required for binding of Escherichia coli hemolysin (HlyA) to erythrocyte membranes , 1990, Infection and immunity.
[100] J. Hacker,et al. Regulatory Interactions among Adhesin Gene Systems of Uropathogenic Escherichia coli , 2007, Infection and Immunity.
[101] M. Schembri,et al. Mellowing Out: Adaptation to Commensalism by Escherichia coli Asymptomatic Bacteriuria Strain 83972 , 2007, Infection and Immunity.
[102] D. Gally,et al. Switches, cross-talk and memory in Escherichia coli adherence. , 2004, Journal of medical microbiology.
[103] Jon R. Armstrong,et al. Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: a comparative genomics approach. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[104] Harry L. T. Mobley,et al. Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract , 2007, Proceedings of the National Academy of Sciences.
[105] S. Hultgren,et al. Establishment of a Persistent Escherichia coli Reservoir during the Acute Phase of a Bladder Infection , 2001, Infection and Immunity.
[106] G. Ulett,et al. Molecular Characterization of the Escherichia coli Asymptomatic Bacteriuria Strain 83972: the Taming of a Pathogen , 2006, Infection and Immunity.
[107] L. Landraud,et al. Rho GTPase-activating bacterial toxins: from bacterial virulence regulation to eukaryotic cell biology. , 2007, FEMS microbiology reviews.
[108] T. Johnson,et al. Comparison of Escherichia coli isolates implicated in human urinary tract infection and avian colibacillosis. , 2005, Microbiology.
[109] A. O’Brien,et al. Cytotoxic Necrotizing Factor Type 1 Production by Uropathogenic Escherichia coli Modulates Polymorphonuclear Leukocyte Function , 2005, Infection and Immunity.
[110] D. Gally,et al. Regulation of P-Fimbrial Phase Variation Frequencies in Escherichia coli CFT073 , 2007, Infection and Immunity.
[111] S. Hultgren,et al. Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[112] H. Mobley,et al. Role of Phase Variation of Type 1 Fimbriae in a Uropathogenic Escherichia coli Cystitis Isolate during Urinary Tract Infection , 2006, Infection and Immunity.
[113] R. Glockshuber,et al. Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding. , 2001, Journal of cell science.
[114] K. Kim,et al. The K1 capsule modulates trafficking of E. coli‐containing vacuoles and enhances intracellular bacterial survival in human brain microvascular endothelial cells , 2003, Cellular microbiology.
[115] P. Boquet,et al. CNF1 Exploits the Ubiquitin-Proteasome Machinery to Restrict Rho GTPase Activation for Bacterial Host Cell Invasion , 2002, Cell.